The Laryngeal Mask Airway (LMA) Supreme™ is a new supraglottic airway incorporating features of the LMA Proseal™, LMA Fastrach™ and LMA Unique™. We evaluated the LMA Supreme in 100 patients with normal airways having elective surgery. Our success rates of insertion and ventilation were 96% at the first attempt and 100% after two attempts. The median time to successful placement was 15 seconds (interquartile range 12 to 18 seconds). Forty-five patients breathed spontaneously and 55 patients had controlled ventilation. The incidence of blood staining on removal was 7% and 7% of patients had mild sore throat one hour postoperatively. One patient who had been placed in the left lateral position during surgery had left lingual nerve palsy postoperatively, which recovered completely after one month. Our findings suggest that in patients with normal airways, the LMA Supreme is easy to insert and provides a satisfactory airway with adequate seal pressures for ventilation.
The Laryngeal Mask Airway Supreme™ (LMA Supreme, The Laryngeal Mask Company, Singapore) is a relatively new single-use laryngeal mask airway which incorporates features of the LMA ProSeal™, LMA Fastrach™ and LMA Unique™. The LMA Supreme has an anatomically shaped semi-rigid airway tube similar to the LMA Fastrach, which enables insertion without the need for an introducer or for the operator to insert his/her fingers into the patient's mouth. The LMA Supreme has a gastric access channel built within the airway tube. It has a high-volume low-pressure cuff that is structured to minimise folding over during insertion. It also has a fixation tab to aid fixation of the device after insertion.
Early work on the LMA Supreme found high success rates of insertion, and a study comparing the LMA Proseal and LMA Supreme in 36 female patients found similar insertion success rates, glottis seal pressure and gastric access 1, 2 . The LMA Supreme has also been used successfully in resuscitation and in the management of difficult airways [3] [4] [5] . In this study, we investigated the clinical efficacy of the LMA Supreme in 100 patients with normal airways undergoing general anaesthesia for elective surgery in our institution.
MATERIALS AND METHODS
We obtained approval from our institution review board and written informed consent from all patients. We recruited 100 consecutive adult patients, between 21 and 80 years of age, with an American Society of Anesthesiologists physical status score of I to III, who were having general anaesthesia for elective surgery. We excluded patients who had not fasted preoperatively, were at risk of aspiration, were pregnant, had upper airway pathology, had mouth opening less than 2 cm or who were having surgery expected to last more than three hours. We also excluded patients who required prone positioning for surgery.
We applied routine monitoring in all patients prior to induction of anaesthesia. We supported the patients' heads on a silicone head ring of 4 cm height. We completely deflated the LMA Supreme cuff and applied a water-based lubricant to the posterior surface of the cuff and airway tube before use. We used size 3 LMA Supremes for patients weighing less than 50 kg, size 4 for those
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Anaesthesia and Intensive Care, Vol. 38, No. 3, May 2010 between 50 and 70 kg and size 5 for those above 70 kg, in accordance with the manufacturer's recommendations. After preoxygenation, we induced anaesthesia with fentanyl to 2 µg.kg -1 , propofol 2 to 2.5 mg.kg -1 and maintained anaesthesia with sevoflurane at an end-tidal concentration of 2 to 3% in oxygen during airway manipulation. In patients who required neuromuscular blockade to facilitate surgery, we used atracurium 0.5 mg.kg -1 given three minutes prior to the insertion of the airway.
Insertion of the LMA Supreme was performed when jaw relaxation was considered adequate by lack of motor response to jaw thrust. We inserted the LMA Supreme using a single-handed rotational insertion technique with the patient's head in semiextension. We allowed up to three attempts at LMA Supreme insertion. We inflated the cuff with 20, 25 and 30 ml of air for size 3, 4 and 5 LMA Supremes respectively. In patients who were not given atracurium, we assisted ventilation until the patients started breathing. In patients who were given atracurium, we started positive pressure ventilation using tidal volumes of 7 ml.kg -1 . In all cases, the LMA Supreme was connected via a disposable catheter mount to the anaesthetic circuit.
We taped the LMA Supreme to the patient's face, applying the tape over the fixation tab. We did not force the LMA deeper in during taping. We noted the distance from the tab to the patient's lip. If the distance was 0.5 to 2.5 cm, we did not change the size of the LMA Supreme. If the distance was less than 0.5 cm, with the tab in contact with the lip, we changed the LMA Supreme to the next available larger size. If the distance was greater than 2.5 cm, we changed to the next smaller size.
After taping the LMA Supreme, we inserted a well lubricated 14 FG gastric tube through the gastric access channel and confirmed successful insertion into the stomach by auscultation over the stomach during injection of 10 ml of air into the gastric tube.
We adjusted the cuff pressure to 60 cmH 2 O and measured the glottis seal pressure at this intracuff pressure with a fresh gas flow of 3 l.minute -1 oxygen. We closed the expiratory valve of the circle anaesthetic breathing system and noted the airway pressure in the breathing system at which there was equilibration 6 , or up to a maximum pressure of 40 cmH 2 O even if it had not equilibrated. After measurement of seal pressures, we reduced the intracuff pressure to 25 cmH 2 O for the remainder of anaesthesia.
Our criteria for diagnosing malposition of the LMA Supreme were failure to ventilate the lungs, gas leak from the oropharynx during ventilation, gas leak from the gastric access channel or failure to insert a gastric tube through the access channel despite being able to ventilate the lungs via the LMA Supreme. If we diagnosed malposition, we removed the LMA Supreme and carried out facemask ventilation with 100% oxygen before reattempting insertion. After successful LMA Supreme insertion and ventilation, surgery proceeded as planned. At the end of anaesthesia, we removed the LMA Supreme when the patient had opened his/her eyes in the post anaesthesia care unit.
We recorded the success rate of LMA Supreme insertion at the first attempt and the number of insertion attempts. We noted the presence or absence of blood on the LMA Supreme. An assistant measured the time for successful insertion and ventilation through the LMA Supreme. This was the time the facemask was first lifted off the patient's face to the time the first breath was successfully delivered through the LMA Supreme, confirmed by end-tidal capnography. We also noted the presence of sore throat one hour after the end of anaesthesia. The patients graded the severity of the sore throat on a three-point scale: mild, moderate or severe.
We used means and standard deviation to describe continuous data, medians and interquartile ranges for non-parametric data and percentages for categorical data.
RESULTS
The patients' characteristics are as described in Table 1 . Clinical performance of the LMA Supreme was described in Table 2 . We successfully inserted the LMA Supreme at the first attempt in 96 patients and at the second attempt in four patients. One patient required an up-sizing of LMA Supreme from size 3 to size 4, two patients required downsizing of LMA Supreme from size 4 to size 3. One patient required reinsertion of the device due to failure to insert a gastric tube. The second attempt was successful. We encountered difficulties in facemask ventilation in four patients, but were able to insert the LMA Supreme successfully at the first attempt in all four. The overall success rate of insertion of the LMA Supreme was 100%. The median time for successful insertion was 15 seconds (interquartile range 12 to 18). We successfully inserted the gastric tube at first attempt in 99 patients. The mean glottis seal pressure was 25 cmH 2 O (standard deviation 6.5, range 10 to 51 cmH 2 O). Eighty percent of patients had seal pressures greater than or equal to 20 cmH 2 O and 20% seal pressures greater than or equal to 30 cmH 2 O.
In seven patients we noted a small amount of blood staining on the LMA Supreme after its removal at the end of anaesthesia. Seven patients had mild sore throat in the post-anaesthesia care unit. The presence of blood staining of the device did not appear to be associated with the subsequent development of sore throat in our study (data not shown). No patient had oxygen desaturation (less than 95%), dental trauma or laryngospasm. One patient who had knee arthroscopy in the supine position followed by bone marrow harvest in the lateral position for 30 minutes noted altered sensation in his tongue and a mild sore throat immediately after surgery. He reported specific loss of taste sensation and reduced touch sensation in the anterior half of the left side of his tongue 18 hours after surgery. He had loss of two-point discrimination in this part of his tongue during testing with a pair of pointed forceps. There was no alteration in tongue movements, speech or swallowing and his sore throat had resolved. The mucosa overlying the left ramus of his mandible was tender when palpated. We made a diagnosis of lingual nerve neuropraxia. We treated the patient with intravenous dexamethasone 8 mg, followed by twice daily doses of oral dexamethasone 4 mg for two days. He had complete recovery after one month.
DISCUSSION
We found high first attempt and overall success rates of LMA Supreme insertion and ventilation using three sizes in patients with normal airways in our institution. Ventilation was achieved within 30 seconds of initiation of first insertion attempt in most patients. This was comparable to that for LMA Proseal (range 18 to 41 seconds) and LMA Classic (range 9 to 34 seconds) in previous studies 7 . In most patients, there was no visible blood staining at removal, suggesting that there was little mucosal trauma.
The LMA Supreme was designed as a single-use device combining the features of earlier laryngeal mask airways to enable easy insertion, fixation and gastric access. Our high success rates and the short insertion times reflect the ease of use of this new laryngeal mask airway by relative novices with the LMA Supreme. We found it advantageous not to have to insert our fingers into the patient's mouth during insertion and to not need an introducer. The gastric access channel not only enabled the passage of a gastric tube, but also helped in diagnosing malposition (e.g. gas leakage from the channel or inability to pass a gastric tube through this channel).
The low amount of blood staining (7%), which suggests a low incidence of mucosal injury, was encouraging. Mucosal trauma from the LMA Proseal had been reported to range from 3 to 28% (mean 10.8%) 7 . The 7% incidence of sore throat in our study Visible blood staining of the LMA Supreme at removal, n (%) 7 (7) Sore throat at 1 hour postoperatively, n (%) 7 (7) Values are expressed as number (percentage) of patients, mean (standard deviation) or median (interquartile range). LMA=laryngeal mask airway.
also is similar to other reports of 12 and 0% with the LMA Supreme 1,4 and with rates reported for the LMA Proseal (2 to 49%) 7 . The LMA Supreme's oval-shaped airway tube helps prevent rotation and the fixation tab aids in evaluation of correct sizing of the airway. The introduction of this single-use device is timely with the current concerns about infection transmission with reusable airway devices 8 .
The LMA Supreme may have disadvantages. Although the seal pressures were comparable to that reported for the LMA Proseal, the seal pressures were less than 15 cmH 2 O in six patients. Although there was no difficulty with positive pressure ventilation in these patients, this may limit the LMA Supreme's usefulness when higher inspiratory pressures are required. Second, the relative rigidity of the airway tube may result in pressure on the cervical spine vertebrae, mucosa and nerves. In particular, we are concerned that this may have been a factor in the lingual nerve palsy in one patient, although the cause of nerve compression injury was unclear. There were no other risk factors for nerve injury in this patient. We had maintained the intracuff pressure at 25 cmH 2 O after measurement of seal pressure and had not used nitrous oxide. We had not carried out laryngoscopy and had not placed his neck in extreme positions, and are unlikely to have stretched his left lingual nerve. Nerve injury may also be due to hypotension and ischaemia, but this patient was normotensive throughout surgery. As neuroinflammation may occur even without severe nerve injury, we started early anti-inflammatory treatment with dexamethasone postoperatively, with the aim of preventing chronic pain and dysaesthesia.
Lingual nerve injury is a rare complication that has also been reported after the use of other laryngeal mask airways 9, 10 . The lingual nerve may be compressed against the ramus of the mandible as it passes between the medial pterygoid muscle and the ramus and over the superior constrictor to reach the tongue. In this patient, the ipsilateral tenderness over the ramus suggests that the left lingual nerve may have been compressed by the airway tube of the LMA Supreme when the patient was positioned in the left lateral position. The cuff of the LMA Supreme may also have caused compression, although the device appeared to be well placed with a good seal and no leak. Further studies and case series are required to investigate association between nerve injury and patient position.
A crossover study comparing the LMA Supreme and LMA Proseal in female patients having controlled ventilation found similar success rates of insertion, seal pressures and gastric access 2 . A similar study in female patients found similar success rates and similar position of the airway when evaluated with a fibreoptic bronchoscope, but found lower seal pressures with the LMA Supreme and higher intracuff pressures with the LMA Proseal 11 . Our data using the different LMA Supreme sizes in spontaneous and controlled ventilation concur with their findings of the ease of use of the LMA Supreme. Similar to earlier laryngeal mask airways, the LMA Supreme may have a role as an emergency airway device when mask ventilation and/or tracheal intubation are difficult 4 . The LMA Supreme has also been used during cardiopulmonary resuscitation 3 . Its ease of use by novice users suggests that it may be a helpful device for emergency use outside of the operating room by non-anaesthetists.
A major limitation of our study is that it is not a comparative study with other laryngeal masks and supraglottic airways. Second, we included only those patients with normal airways. We also excluded very obese patients and patients having emergency surgery. This will limit the generalisability of our results to the general population. Third, although this study reflects use of the LMA Supreme by relative novices, we were experienced with the LMA Proseal, with over 500 uses by each investigator. Our results may not apply to operators completely new to laryngeal mask airways.
In conclusion, we found the LMA Supreme easy to insert with a high rate of optimal positioning at the first insertion attempt in patients with normal airways. We found that it provided adequate glottis seal pressures for controlled ventilation during anaesthesia for elective surgery. These findings suggest that the LMA Supreme is a promising singleuse, disposable airway.
